Oct 05, 2026
1:100
For every 100 shares held, investors received 1. The price per share adjusted from $75.30 to $7530.00.
The split itself did not change the total investment value.
BioView Ltd. (TASE:BIOV) operates in the Medical specialties industry.
BioView Ltd. company overviewBioView Ltd.'s most recent stock split was on October 5, 2026. It was a 1-for-100 reverse split, so shareholders received 1 share for every 100 they held.
BioView Ltd. (TASE:BIOV) has split its stock 3 times: a 10-for-1 split on December 24, 2023, a 1-for-10 reverse split on June 1, 2026, and a 1-for-100 reverse split on October 5, 2026.
BioView Ltd. has split its stock 3 times. This history records 3 splits between December 24, 2023 and October 5, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In BioView Ltd.'s 1-for-100 reverse split on October 5, 2026, every 100 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
BioView Ltd. has not announced a new split in our records. Its most recent split was on October 5, 2026, less than a year ago. Companies announce splits in advance, and any new TASE:BIOV split will appear on this page.
Already premium?